Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY: CLDI )

1.360 +0.010 (+0.74%)
Official Closing Price Updated: 8:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 Next >
Why Calidi Biotherapeutics (CLDI) Shares Are Trading Lower
Calidi Biotherapeutics shares are trading lower by 14.3% during Monday's session. The company announced a 1-for-10 reverse stock split. 
Via Benzinga
Calidi to Effect Reverse Stock Split
From Calidi Biotherapeutics, Inc.
Via Business Wire
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
From Calidi Biotherapeutics, Inc.
Via Business Wire
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13
From Calidi Biotherapeutics, Inc.
Via Business Wire
Why Calidi Biotherapeutics is Moving Higher Monday
Calidi and SIGA are partnering in order to advance Calidi's RTNova virotherapy for lung cancer and metastatic solid tumors. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest ones worth watching on Wednesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Dow Surges 250 Points; MongoDB Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Calidi Biotherapeutics (CLDI) Stock Is Getting Hammered
Calidi Biotherapeutics shares are trading lower by 30.7% during Friday's session. The company announced a definitive agreement for the immediate exercise of certain warrants. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Down 1.5%; Gap Shares Spike Higher
Via Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
US Stocks Mostly Higher; Headline PCE Inflation Matches Estimates
Via Benzinga
Topics Economy
Exposures Interest Rates
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
From Calidi Biotherapeutics, Inc.
Via Business Wire
ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
Via ACCESSWIRE
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024
CLDI stock results show that Calidi Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
From Calidi Biotherapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.